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implantation. Technical success was deﬁned as completion of the robotic stent pro-
cedure without either conversion to manual stent positioning or deployment of an
additional stent due to geographic miss. Procedural success was deﬁned as <30%
residual stenosis with no post-procedure adverse outcomes.
RESULTS Five consecutive unselected patients underwent robotic RA stent implan-
tation with the CorPath system between 6/1/12 and 8/30/13. Patient characteristics are
displayed in Table I. Technical and procedural success was achieved in all patients.
CONCLUSIONS Renal stent implantation using the CorPath robotic system is feasible
and effective. Further study is warranted.Table IN[5 patientsAge (yrs) 67.87.7
BSA (m2) 2.00.2
Men 3 (60%)Current/Recent Smoker 1 (20%)Diabetes mellitus 1 (20%)Hypertension 4 (80%)Hyperlipidemia 5 (100%)Prior PCI 2 (40%)Prior CABG 1 (20%)Table IIProcedure Characteristics N[5 patientsRadial (n/%) 3 (60%)Millimeter positioning tool use 5 (100%)Total Fluoroscopy Time (min) 23.36.1
Total Procedure Time (min) 57.510.9
Total Contrast Volume (cc) 65.436.4
Stent diameter (mm) 5.0.09
Technical Success (%) 5 (100%)Procedure Success (%) 5 (100%)CRT-314
Preclinical Evaluation Of Lesion Coverage Using A Multi-electrode Catheter
System For Sympathetic Renal Nerve Ablation
Catherine A. Pipenhagen,1 Boyce Moon,1 Jim Jensen,1 Vasilios Papademetriou2
1St Jude Medical, Plymouth, MN; 2Georgetown University, Potomac, MD
AIM Radio frequency (RF) catheter-based renal artery nerve ablation is under
investigation for the treatment of patients with drug- resistant hypertension. Recent
clinical results suggest that a four quadrant coverage is necessary to achieve optimal
denervation. These results also suggest that increasing the number of ablation lesions
improves denervation effectiveness. In the present study we evaluated the lesion
characteristics and degree of arterial, circumferential coverage with RF ablation using
the EnligHTNTM Multi-Electrode Renal Denervation System in the domestic swine
animal model.
METHODS AND RESULTS Theoretical modeling and preclinical ablation were con-
ducted to develop an arterial lesion coverage algorithm. Twenty three domestic swine
were randomly assigned to either treatment (ablation) groups or sham procedure
groups. Animals in the treatment groups received simultaneous RF energy delivery
from a four electrode basket catheter; whereas animals in the sham procedure groups
were either naïve untreated animals or received only balloon dilation with no energy
delivery. In the treatment arm two RF applications (8 lesions) were delivered per
renal artery. The animals were terminated at three timepoints: acute, 30, and 90 days
after the procedure. Acute necropsy ﬁndings showed four well-demarcated trans-
mural lesions per RF application site on both luminal and adventitial surfaces of each
renal artery. Observed lesion dimensions were 3.0  0.4 width x 2.1  0.3 length mm.
The number of lesions needed for circumferential arterial coverage increased with the
renal artery diameter as follows:
Renal artery diameter (mm)Lesions needed for circumferential coverage
44.4, 55.5, 66.6, 77.7, 88.8
Kidneys were analyzed for norepinephrine (NE) levels at the time of sacriﬁce.
Baseline NE levels were 367119.76 in the naïve animals and 34243 ng/g in the
sham procedure group. The values decreased to 16215 (56% decrease)at 30 days,
and 16443 ng/g (55% decrease) at 90 days in the 30, and 90 day RF treated
groups, respectively. Immunohistochemistry and H&E stains indicated ﬁber inter-
ruption, ﬁber injury or inﬂammation and functional derailment in all affected
ﬁbers.CONCLUSION Renal nerve ablation using the EnligHTNTM Multi-Electrode Dener-
vation System provides uniform transmural lesions with longitudinal, circumferential
arterial coverage. In order to obtain full circumferential coverage, the number of le-
sions needed increases with the renal artery diameter.IMAGINGCTA
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Spatial Relationship Between The Coronary Artery And Coronary Vein By
Computed Tomography: Clinical Importance For Radiofrequency Ablation Within
The Coronary Sinus, Transcatheter Mitral Valve Annuloplasty, And Percutaneous
Coronary Interventions
Yoko Kato
Tokyo Yamate Medical Center, Tokyo, Japan
AIMS Coronary computed tomography angiography (CTA) investigates not only cor-
onary arteries but also coronary veins. The aim of this study was to clarify the
anatomy of the crossing points and adjacent cardiac wall of coronary arteries and
veins and to discuss the clinical relevance.
METHODS AND RESULTS Seventy-six coronary CTA images were retrospectively
reviewed using the slab maximal intensity projection technique. Three vessel pairs
were investigated: (i) the left circumﬂex artery (LCx)/coronary sinus (CS), (ii) the
diagonal branch/anterior interventricular vein, and (iii) the atrioventricular node
branch (#4AV)/posterior interventricular vein. Pattern A was deﬁned when arteries
ran between the vein and the muscle; pattern V was when the vein ran between the
artery and the muscle. Pattern A was detected in 72%, 33%, and 93% of crossing
points (i), (ii), and (iii), respectively. The A-V-A was the predominant pattern com-
bination, accounting for 41% of the patients. The LCx/CS crossing point was adjacent
to the anterior (58%), lateral (34%), or posterior (7%) wall, with distances between
the LCx ostium and the crossing point of 24  7.8, 39  11, and 52  20 mm,
respectively.
CONCLUSION The crossing point anatomy of coronary arteries and veins showed
typical patterns with some variation. These data could be used in clinical settings to
(a) prevent arterial spasm or occlusion by radiofrequency ablation within the CS, (b)
prevent LCx occlusion by the intra-CS implant of the Carillon Mitral Contour Sys-
temTM, and (c) predict the difﬁculty of wiring during percutaneous coronary inter-
vention at the crossing point.
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Ivabradine Versus Metoprolol For Heart Rate Reduction In Computed
Tomography Coronary Angiography
Saurabh Aggarwal,1 Venkata Mahesh Alla,1 Rohit Arora2
1Creighton University School of Medicine, OMAHA, NE; 2Chicago Medical School, North
Chicago, IL
BACKGROUND Ivabradine, a sinus node blocker, has been evaluated in multiple
studies for heart rate reduction in computed tomography coronary angiography
(CTCA). We aimed to performed a meta-analysis of studies comparing Ivabradine with
Metoprolol for the same.
METHODS Pubmed, EBSCO and Cochrane databases were searched for terms “Ivab-
radine”, “Metoprolol”, “computed tomography coronary angiography” and their
combinations. Only studies in English language and reporting data in usable format
were included. Random effects model was used for heterogeneity. A ‘p’ value
of <0.05 was considered signiﬁcant. Review manager was used for statistical analysis.
RESULTS A total of 4 studies with total 357 patients were included. Ivabradine was
found to signiﬁcantly decrease heart rate when compared to metoprolol (Mean dif-
ference -8.02, 95% CI -11.12 to -4.92, p <0.00001).
CONCLUSION Ivabradine use was associated with signiﬁcant reduction in heart rate
when compared to metoprolol in use for computed tomography coronary angiography.
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Fibrous Cap Thickness of Large Lipid-rich Plaques Detected by Intracoronary
Near-infrared Spectroscopy
Mohsin Khan,1 Margaret Chi,2 Zaahir Turfe,2 Sarah Dionne,2 Andrew Schmale,2
Andrew LaCombe,2 Andrew O’Brien,2 Ryan Farley,2 David Klungle,1 Samrath Singh,1
Stacie M. VanOosterhout,1 Ryan D. Madder1
1Frederik Meijer Heart & Vascular Institute, Grand Rapids, MI; 2Michigan State
University College of Human Medicine, Grand Rapids, MI
BACKGROUND A maximum lipid core burden index in 4-mm (maxLCBI4mm) 400 has
been suggested to be a near-infrared spectroscopy (NIRS) signature of plaques that
cause myocardial infarction, yet little is known about the ﬁbrous cap thickness of
lesions having such a large lipid burden. The present study was performed to evaluate
the cap thickness of plaques with a maxLCBI4mm 400.
METHODS We imaged 71 coronary artery segments with NIRS followed by optical
coherence tomography (OCT) in 15 patients with an acute coronary syndrome prior to
stenting. The lipid burden of all plaques was measured by NIRS as maxLCBI4mm.
Fibrous cap thickness was assessed by OCT at 1-mm intervals while blinded to NIRS
images. A thin ﬁbrous cap was deﬁned as a minimum cap thickness <70 microns.
RESULTS Among 71 coronary segments, NIRS detected lipid in 50 (70.4%) and a
maxLCBI4mm 400 in 12 (16.9%). Plaques having a maxLCBI4mm 400 had a thin
ﬁbrous cap by OCT in 10 of 12 cases (83.3%; Figure). Among all lipid-containing pla-
ques detected by NIRS, plaques with a maxLCBI4mm 400 had a thin-ﬁbrous cap more
often than plaques with a maxLCBI4mm <400 (83.3% vs 44.7%; p¼0.02).
CONCLUSION Plaques with a maxLCBI4mm 400 by NIRS frequently have a thin-
ﬁbrous cap byOCT. Further study in a larger series of patients is required to determine if
maxLCBI4mm 400 is a reliable indicator of the presence of a thin-ﬁbrous cap.OCT
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Incomplete Stent Apposition Causes High Shear Flow Disturbances And Delay In
Neointimal Coverage
Nicolas Foin,1 Juan Luis Gutiérrez-Chico,2 Shimpei Nakatani,3 Ryo Torii,4 Renick Lee,1
Christos Bourantas,5 Sayan Sen,6 Sukhjinder Nijjer,6 Ricardo Petraco,6
Yoshinobu Onuma,5 Philip Wong,1 Carlo Di Mario,6 Justin Davies,6 Patrick Serruys6
1National Heart Centre Singapore, Singapore, Singapore; 2Charité- Universitätsmedizin
Berlin, Berlin, Germany; 3ThoraxCenter, Erasmus Medical Center, Rotterdam,
Netherlands; 4University College London, London, United Kingdom; 5ThoraxCenter,
Erasmus Medical Center, Rotterdam, Netherlands; 6Imperial College London, London,
United Kingdom
BACKGROUND Lack of re-endothelialization and neointimal coverage on stent struts
has been put forward as the main underlying mechanism leading to late stent
thrombosis. Incomplete Stent Apposition (ISA) has been frequently observed in pa-
tients with very late stent thrombosis after DES implantation, suggesting a role of ISA
in the pathogenesis of this adverse event. The aim of this study was to evaluate the
impact of different degrees of ISA severity on abnormal shear rate and healing
response with coverage, due to its potential implications for stent optimization in
clinical practice.
METHODS AND RESULTS We characterized ﬂow proﬁle and shear distribution in
different cases of ISA with increasing strut-wall detachment distance (ranging from
100 mm to 500 mm). Protruding strut and strut malapposed with moderate detachment
(ISA detachment distance < 100mm) have minimal disturbance to blood ﬂow as
compared with ﬂoating strut that has more signiﬁcant ISA distance.
In-vivo impact on strut coverage was assessed retrospectively using Optical
Coherence Tomography evaluation on 72 stents (48 patients) sequentially at
baseline and after 6 months follow-up. Analysis of coverage revealed an
important impact of baseline strut-wall ISA distance on the risk of incomplete
strut coverage at follow-up. Malapposed segments with an ISA detachment 300 mm
had 6.1 % and 15.7% of their struts still uncovered at follow-up respectively
(p <0.001).
Finally, a series of stent implanted with a controlled under-expansion using an in-
vivo animal model conﬁrmed the impact stent apposition as well as the effect of
platform strut characteristics on the coverage process.
CONCLUSIONS Flow disturbances and risk of delayed strut coverage both increase
with ISA detachment distance. Insights from this study are important for under-
standing malapposition as a quantitative, rather than binary phenomenon, and to
deﬁne the threshold of ISA detachment that might beneﬁt from optimization during
stent implantation.CRT-404
Is High Pressure Post-Dilation Safe In Bioresorbable Vascular Scaffolds? Optical
Coherence Tomography Observations after Non-Compliant Balloons Inﬂated at
more than 24 Atmospheres
Enrico Fabris,1 Gianluca Caiazzo,1 Ismail Dogu Kilic,1 Roberta Serdoz,1
Gioel Gabrio Secco,1 Nicolas Foin,2 Carlo Di Mario1
1NIHR Biomedical Research Unit, Royal Brompton & Hareﬁeld NHS Foundation Trust,
London, United Kingdom; 2National Heart Centre Singapore, Singapore, Singapore
BACKGROUND Because of concerns about the risk of bioresorbable drug-eluting
scaffolds (BVS) damage, post-dilation was not recommended and applied in the
existing randomized studies and most registries. Recent real world data suggest
incomplete BVS expansion cause higher rates of thrombosis. In vivo conﬁrmation of
the safety of high pressure post-dilation (HPPD) is of paramount importance. Optical
coherence tomography (OCT) was used to investigate integrity and expansion of BVS
after HPPD.
METHODS Data from ﬁnal OCT examination of consecutive implanted BVS, post
dilated with non-compliant (NC) balloons at pressure 24 atm were analyzed. The
following stent performance indices were assessed with OCT: mean and minimal
lumen and scaffold area, residual area stenosis (RAS), incomplete strut apposition
(ISA), tissue prolapse, eccentricity index (EI), symmetry index (SI), strut fractures and
edge dissections.
RESULT Twenty-two BVS post dilated at high pressure were analyzed. The
average maximal post-dilation balloon inﬂation (maxPD) was 283 atm. High
pressure OPN NC Balloon (SIS Medical AG, Winterthur Switzerland) was used in
41% of post-dilations with a maximal PD of 304.7 atm. Final mean and minimal
lumen area were 6.81.4 and 5.51.4 mm2, respectively. OCT showed low per-
centage of RAS (169.6%), and low percentage of ISA (1.82.4%). Mean EI was
0.860.02 and SI 0.350.14. OCT analysis showed one edge dissection and no
scaffold fractures.
CONCLUSIONS BVS deployment optimization using HPPD does not cause BVS
disruption and is associated with a good BVS expansion, low strut malapposition and
edge dissection.
